Skip to content

Clinical efficacy observation of auricular point application and pressing therapy in the treatment of insomnia due to deficiency of both the heart and spleen

Clinical efficacy observation of auricular point application and pressing therapy in the treatment of insomnia due to deficiency of both the heart and spleen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000730
Enrollment
Unknown
Registered
2026-03-25
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Auricular Acupressure Group:Take the Subcortical, Shenmen, Zhen, Heart, Spleen, and Chui Qian (6 acupoints) and apply one Wangbuliuxing seed to each.
Acupoint Reinforcement Group:Apply one Wangbuliuxing seed to each of the 4 main acupoints (Subcortical, Shenmen, Zhi, Heart)
apply one Wangbuliuxing seed to each of the 2 auxiliary acupoints (Spleen, Chuiqian).
Main Acupoint Reinforcement Group:Apply two Wangbuliuxing seeds to the four main acupoints: Subcortical, Shenmen, Jiache, and Heart
apply one Wangbuliuxing seed to the two auxiliary acupoints: Spleen and Cheqian.
Main Auxiliary Points Reinforcement Group:Take the Subcortical, Shenmen, Zhongzhu, Heart, Spleen, and Chuíqián acupoints, applying two Vaccaria seeds to each of the six acupoints.

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for both Western medicine and traditional Chinese medicine (TCM) syndrome identification; (2) No restrictions on gender, age 18~75 years ; (3) Pittsburgh Sleep Quality Index (PSQI) score >7 points; (4) No prior use of hypnotics, or cessation of use for more than 1 month; (5) Not participating in other clinical studies; (6) Able to clearly express personal thoughts and feelings, with no mental disorders, intellectual disabilities, etc.; (7) Fully informed about relevant matters, voluntarily participates in this trial, and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with severe primary diseases of the heart, brain, liver, kidney, and hematopoietic system, as well as acute illnesses, infectious diseases, and malignant tumors; (2) Total score of the 14-item Hamilton Anxiety Scale (HAMA) =14 points; total score of the 17-item Hamilton Depression Scale (HAMD) =17 points; (3) Individuals with auricular skin damage, inflammation, or allergies to adhesive tape or alcohol; (4) Pregnant and lactating women; (5) Individuals with alcohol abuse, substance abuse, or dependence; (6) Individuals with cognitive or communication impairments.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index Scale;Insomnia Severity Index Scale;Heart-Spleen Deficiency Type Insomnia Traditional Chinese Medicine (TCM) Syndrome Scoring Scale;

Secondary

MeasureTime frame
Hamilton Depression Rating Scale;Hamilton Anxiety Rating Scale;

Countries

China

Contacts

Public ContactShao Shuai, Xie Wei

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

1508220133@qq.com17778778150

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026